May 20, 2026

CGRP Therapies Reduced Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies

Conexiant

May 18, 2026

Could Digital Twins Forecast Forensic Risk?

Researchers outline a proposed three-level framework spanning patient monitoring, ward operations, and forensic system planning.

Conexiant

May 14, 2026

When to Choose MRN Over Ultrasound

Proximal location, multi-nerve involvement, and multi-region extent favor MRN; ultrasound retains value for dynamic assessment and metal artifact–limited cases.

Conexiant

May 14, 2026

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma

Conexiant

May 13, 2026

Preop Cognitive Impairment Tied to TKA Delirium

Older patients with documented cognitive impairment also experienced greater postoperative functional decline following elective total knee arthroplasty

Conexiant

May 13, 2026

Chronotherapy Trial Tests Sleep Timing in Adolescents

Two-week chronotherapy trial evaluates circadian phase, sleep duration, and alignment outcomes.

Conexiant

May 11, 2026

Bowel Management May Cut Wet Days in Kids

“These findings underscore the importance of adequately treating constipation as a prerequisite for optimizing the effect of standard urotherapy."

Conexiant

May 08, 2026

Do Head Hits Shift the Gut Microbiome?

A small observational study in collegiate football players found microbiome associations after nonconcussive head impacts, though findings were limited by severe underpowering and high attrition

Conexiant

May 06, 2026

Side Effects: Progress, with Asterisks

Burnout is easing. Sleep science is getting weird. And dental schools have been winging cadaver training for 50 years. This week's research is full of good news that immediately complicates itself.

Conexiant

May 06, 2026

Semaglutide Tested in Alcohol Use Disorder

Randomized trial found improvements in alcohol consumption and metabolic outcomes, with gastrointestinal adverse events more common with treatment

Conexiant